Sign in

CIK 0001815442

  • Large accelerated filer

Kymera Therapeutics, Inc.

Sign in to watch
Ticker
KYMR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812992166
Phone
+1 857-285-5314
Business address
500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
Former names
Kymera Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,158,214
in 2 filings, $3.4M under 10b5-1 plans

Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 68 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-01 Gollob Jared Chief Medical Officer Grant or award +24,375 99,084
2024-03-01 Gollob Jared Chief Medical Officer Grant or award · Stock Option (Right to Buy) +146,250 146,250
2024-03-01 Chadwick Jeremy G Chief Operating Officer Grant or award +13,425 46,758
2024-03-01 Chadwick Jeremy G Chief Operating Officer Grant or award · Stock Option (Right to Buy) +80,548 80,548
2024-03-01 Chiniara Ellen Chief Legal Officer Grant or award +21,755 55,960
2024-03-01 Chiniara Ellen Chief Legal Officer Grant or award · Stock Option (Right to Buy) +130,531 130,531
2024-03-01 Mainolfi Nello Chief Executive Officer Grant or award · Stock Option (Right to Buy) +530,000 530,000
2024-03-01 Jacobs Bruce N. Chief Financial Officer Grant or award +31,250 146,285
2024-03-01 Jacobs Bruce N. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +187,500 187,500
2024-02-27 Gollob Jared Chief Medical Officer Exercise or conversion 10b5-1 +400 $2.08 $832 75,109
2024-02-27 Gollob Jared Chief Medical Officer Sale 10b5-1 −400 $45.00 $18K 74,709
2024-02-27 Gollob Jared Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −400 62,483
2024-02-21 Albers Jeffrey W. Director Exercise or conversion 10b5-1 +4,385 $10.34 $45K 4,385
2024-02-21 Albers Jeffrey W. Director Sale 10b5-1 −4,385 $39.05 $171K 0
2024-02-21 Albers Jeffrey W. Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −4,385 16,349
2024-02-20 Albers Jeffrey W. Director Exercise or conversion 10b5-1 +615 $10.34 $6K 615
2024-02-20 Albers Jeffrey W. Director Sale 10b5-1 −615 $39.07 $24K 0
2024-02-20 Albers Jeffrey W. Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −615 20,734
2024-02-09 Gollob Jared Chief Medical Officer Exercise or conversion 10b5-1 +46,137 $2.08 $96K 120,846
2024-02-09 Gollob Jared Chief Medical Officer Sale 10b5-1 −38,739 $35.39 $1.4M 82,107

Page 30 of 41 · 810 trades